Log in to save to my catalogue

Randomized Trial of Tocilizumab in Systemic Juvenile Idiopathic Arthritis

Randomized Trial of Tocilizumab in Systemic Juvenile Idiopathic Arthritis

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1242080091

Randomized Trial of Tocilizumab in Systemic Juvenile Idiopathic Arthritis

About this item

Full title

Randomized Trial of Tocilizumab in Systemic Juvenile Idiopathic Arthritis

Publisher

Waltham, MA: Massachusetts Medical Society

Journal title

The New England journal of medicine, 2012-12, Vol.367 (25), p.2385-2395

Language

English

Formats

Publication information

Publisher

Waltham, MA: Massachusetts Medical Society

More information

Scope and Contents

Contents

In a randomized trial involving children with severe systemic juvenile idiopathic arthritis, the anti–interleukin-6 receptor antibody tocilizumab was effective (response rate, 85% with tocilizumab vs. 24% with placebo). Adverse events included serious infections and neutropenia.
Systemic juvenile idiopathic arthritis (JIA) is characterized by ch...

Alternative Titles

Full title

Randomized Trial of Tocilizumab in Systemic Juvenile Idiopathic Arthritis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_1242080091

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1242080091

Other Identifiers

ISSN

0028-4793

E-ISSN

1533-4406

DOI

10.1056/NEJMoa1112802

How to access this item